DDInter701 DDInter1082
Etonogestrel molecule is a 3-ketodesogestrel or 19-nortestosterone which is a synthetic biologically active metabolite of progestin desogestrel. The first product including etonogestrel was developed by the Merck subsidiary Organon and FDA approved in 2001.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Etonogestrel {u} (Compound) resembles {v} (Compound) Nandrolone decanoate
Etonogestrel {u} (Compound) resembles {v} (Compound) Levonorgestrel
Etonogestrel {u} (Compound) binds {v} (Gene) PGR
Etonogestrel {u} (Compound) is included by {v} (Pharmacologic Class) Progesterone Congeners
Etonogestrel {u} (Compound) causes {v} (Side Effect) Contraceptive device complication
Etonogestrel {u} may cause a minor interaction that can limit clinical effects when taken with {v} Pioglitazone
Etonogestrel {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ivacaftor
Etonogestrel {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Infliximab
Etonogestrel {u} may lead to a major life threatening interaction when taken with {v} Brigatinib
Etonogestrel (Compound) resembles Nandrolone decanoate (Compound)
Etonogestrel (Compound) resembles Levonorgestrel (Compound)
Etonogestrel (Compound) binds PGR (Gene)
Etonogestrel (Compound) is included by Progesterone Congeners (Pharmacologic Class)
Etonogestrel (Compound) causes Contraceptive device complication (Side Effect)
Etonogestrel may cause a minor interaction that can limit clinical effects when taken with Pioglitazone
Etonogestrel may cause a moderate interaction that could exacerbate diseases when taken with Ivacaftor
Etonogestrel may cause a moderate interaction that could exacerbate diseases when taken with Infliximab
Etonogestrel may lead to a major life threatening interaction when taken with Brigatinib